A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer

por Mercalli, A, Sordi, V, Formicola, R, Dandrea, M, Beghelli, S, Scarpa, A, Di Carlo, V, Reni, M, Piemonti, L
Publicado 2007